These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1756857)

  • 1. Characterization of trypsinogens 1 and 2 in two human pancreatic adenocarcinoma cell lines; CFPAC-1 and CAPAN-1.
    Miszczuk-Jamska B; Merten M; Guy-Crotte O; Amouric M; Clemente F; Schoumacher RA; Figarella C
    FEBS Lett; 1991 Dec; 294(3):175-8. PubMed ID: 1756857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trypsinogen expression by two human pancreatic cell lines CFPAC-1 and CAPAN-1. Modulation during spontaneous and induced cell growth.
    Miszczuk-Jamska B; Merten M; Renaud W; Guy-Crotte O; Figarella C
    Int J Pancreatol; 1994 Aug; 16(1):61-9. PubMed ID: 7806913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies to human pancreatic trypsin 1 inhibit the activation of human trypsinogens 1 and 2.
    Guy-Crotte O; Miszczuk-Jamska B; Brayle A; Lafont P; Figarella C
    Eur J Biochem; 1992 Feb; 204(1):133-6. PubMed ID: 1371252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative studies on the mechanism of activation of the two human trypsinogens.
    Colomb E; Figarella C
    Biochim Biophys Acta; 1979 Dec; 571(2):343-51. PubMed ID: 508771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cationic trypsinogen produced by human pancreatic ductal cancer has the characteristics of spontaneous activation and gelatinolytic activity in the presence of proton.
    Ohta T; Tajima H; Fushida S; Kitagawa H; Kayahara M; Nagakawa T; Miwa K; Yamamoto M; Numata M; Nakanuma Y; Kitamura Y; Terada T
    Int J Mol Med; 1998 Apr; 1(4):689-92. PubMed ID: 9852283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The two human trypsinogens. Evidence of complex formation with basic pancreatic trypsin inhibitor-proteolytic activity.
    Colomb E; Figarella C; Guy O
    Biochim Biophys Acta; 1979 Oct; 570(2):397-405. PubMed ID: 40607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the activation of canine trypsinogens in vitro.
    Borgström A; Ohlsson K
    Biochim Biophys Acta; 1979 Dec; 571(2):284-93. PubMed ID: 92342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of one- and two-chain forms of trypsinogen 1 produced by a human gastric adenocarcinoma cell line.
    Koshikawa N; Yasumitsu H; Nagashima Y; Umeda M; Miyazaki K
    Biochem J; 1994 Oct; 303 ( Pt 1)(Pt 1):187-90. PubMed ID: 7945238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On bovine and porcine anionic trypsinogens.
    Louvard MN; Puigserver A
    Biochim Biophys Acta; 1974 Nov; 371(1):177-85. PubMed ID: 4429716
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunoreactive anionic and cationic trypsin in human serum.
    Kimland M; Russick C; Marks WH; Borgström A
    Clin Chim Acta; 1989 Sep; 184(1):31-46. PubMed ID: 2598466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ostrich trypsinogen: purification, kinetic properties and characterization of the pancreatic enzyme.
    Bodley MD; Naudé RJ; Oelofsen W; Pátthy A
    Int J Biochem Cell Biol; 1995 Jul; 27(7):719-28. PubMed ID: 7648428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemistry and clinical role of trypsinogens and pancreatic secretory trypsin inhibitor.
    Paju A; Stenman UH
    Crit Rev Clin Lab Sci; 2006; 43(2):103-42. PubMed ID: 16517420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The guinea pig pancreas secretes a single trypsinogen isoform, which is defective in autoactivation.
    Ozsvári B; Hegyi P; Sahin-Tóth M
    Pancreas; 2008 Aug; 37(2):182-8. PubMed ID: 18665081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of beta-trypsin by affinity chromatography of enterokinase-activated bovine trypsinogen.
    Liepnieks JJ; Light A
    Anal Biochem; 1974 Aug; 60(2):395-404. PubMed ID: 4858522
    [No Abstract]   [Full Text] [Related]  

  • 15. Expression of trypsin in human cancer cell lines and cancer tissues and its tight binding to soluble form of Alzheimer amyloid precursor protein in culture.
    Miyata S; Koshikawa N; Higashi S; Miyagi Y; Nagashima Y; Yanoma S; Kato Y; Yasumitsu H; Miyazaki K
    J Biochem; 1999 Jun; 125(6):1067-76. PubMed ID: 10348909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of mutated cationic trypsinogen reduces cellular viability in AR4-2J cells.
    Gaiser S; Ahler A; Gundling F; Kruse ML; Savkovic V; Selig L; Teich N; Tomasini R; Dagorn JC; Mössner J; Keim V; Bödeker H
    Biochem Biophys Res Commun; 2005 Aug; 334(2):721-8. PubMed ID: 16036133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of acinar and ductal products in Capan-1 cells growing in synthetic serum and serum-free media.
    Fernández E; Fallon MJ; Frazier ML; de Llorens R; Cuchillo CM
    Cancer; 1994 May; 73(9):2285-95. PubMed ID: 7513248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesotrypsin: a new inhibitor-resistant protease from a zymogen in human pancreatic tissue and fluid.
    Rinderknecht H; Renner IG; Abramson SB; Carmack C
    Gastroenterology; 1984 Apr; 86(4):681-92. PubMed ID: 6698368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of the trypsinogen activation by enterokinase and trypsin.
    Varón R; Havsteen BH; Vázquez A; García M; Valero E; García Cánovas F
    J Theor Biol; 1990 Jul; 145(1):123-31. PubMed ID: 2214804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tetra-aspartate motif in the activation peptide of human cationic trypsinogen is essential for autoactivation control but not for enteropeptidase recognition.
    Nemoda Z; Sahin-Tóth M
    J Biol Chem; 2005 Aug; 280(33):29645-52. PubMed ID: 15970597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.